Effect of UGT1A1, UGT1A3, DIO1 and DIO2 polymorphisms on L-thyroxine doses required for TSH suppression in patients with differentiated thyroid cancer

nork Santoro, Ana B, Vargens, Daniela D, Barros Filho, Mateus de Camargo, Bulzico, Daniel A, Kowalski, Luiz Paulo, Meirelles, Ricardo M R, Paula, Daniela P, Neves, Ronaldo R S, Pessoa, Cencita N, Struchine, Claudio J, Suarez-Kurtz, Guilherme
Argitaratua izan da Br J Clin Pharmacol (2014)